位置:首页 > 蛋白库 > ABP1_YEAST
ABP1_YEAST
ID   ABP1_YEAST              Reviewed;         592 AA.
AC   P15891; D6VR88;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   03-AUG-2022, entry version 210.
DE   RecName: Full=Actin-binding protein;
GN   Name=ABP1; OrderedLocusNames=YCR088W; ORFNames=YCR88W;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes;
OC   Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2405279; DOI=10.1038/343288a0;
RA   Drubin D.G., Mulholland J., Zhu Z., Botstein D.;
RT   "Homology of a yeast actin-binding protein to signal transduction proteins
RT   and myosin-I.";
RL   Nature 343:288-290(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=1574125; DOI=10.1038/357038a0;
RA   Oliver S.G., van der Aart Q.J.M., Agostoni-Carbone M.L., Aigle M.,
RA   Alberghina L., Alexandraki D., Antoine G., Anwar R., Ballesta J.P.G.,
RA   Benit P., Berben G., Bergantino E., Biteau N., Bolle P.-A.,
RA   Bolotin-Fukuhara M., Brown A., Brown A.J.P., Buhler J.-M., Carcano C.,
RA   Carignani G., Cederberg H., Chanet R., Contreras R., Crouzet M.,
RA   Daignan-Fornier B., Defoor E., Delgado M.D., Demolder J., Doira C.,
RA   Dubois E., Dujon B., Duesterhoeft A., Erdmann D., Esteban M., Fabre F.,
RA   Fairhead C., Faye G., Feldmann H., Fiers W., Francingues-Gaillard M.-C.,
RA   Franco L., Frontali L., Fukuhara H., Fuller L.J., Galland P., Gent M.E.,
RA   Gigot D., Gilliquet V., Glansdorff N., Goffeau A., Grenson M., Grisanti P.,
RA   Grivell L.A., de Haan M., Haasemann M., Hatat D., Hoenicka J.,
RA   Hegemann J.H., Herbert C.J., Hilger F., Hohmann S., Hollenberg C.P.,
RA   Huse K., Iborra F., Indge K.J., Isono K., Jacq C., Jacquet M., James C.M.,
RA   Jauniaux J.-C., Jia Y., Jimenez A., Kelly A., Kleinhans U., Kreisl P.,
RA   Lanfranchi G., Lewis C., van der Linden C.G., Lucchini G.,
RA   Lutzenkirchen K., Maat M.J., Mallet L., Mannhaupt G., Martegani E.,
RA   Mathieu A., Maurer C.T.C., McConnell D., McKee R.A., Messenguy F.,
RA   Mewes H.-W., Molemans F., Montague M.A., Muzi Falconi M., Navas L.,
RA   Newlon C.S., Noone D., Pallier C., Panzeri L., Pearson B.M., Perea J.,
RA   Philippsen P., Pierard A., Planta R.J., Plevani P., Poetsch B., Pohl F.M.,
RA   Purnelle B., Ramezani Rad M., Rasmussen S.W., Raynal A., Remacha M.A.,
RA   Richterich P., Roberts A.B., Rodriguez F., Sanz E.,
RA   Schaaff-Gerstenschlaeger I., Scherens B., Schweitzer B., Shu Y., Skala J.,
RA   Slonimski P.P., Sor F., Soustelle C., Spiegelberg R., Stateva L.I.,
RA   Steensma H.Y., Steiner S., Thierry A., Thireos G., Tzermia M.,
RA   Urrestarazu L.A., Valle G., Vetter I., van Vliet-Reedijk J.C., Voet M.,
RA   Volckaert G., Vreken P., Wang H., Warmington J.R., von Wettstein D.,
RA   Wicksteed B.L., Wilson C., Wurst H., Xu G., Yoshikawa A., Zimmermann F.K.,
RA   Sgouros J.G.;
RT   "The complete DNA sequence of yeast chromosome III.";
RL   Nature 357:38-46(1992).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [4]
RP   PROTEIN SEQUENCE OF 2-13 AND 97-112, CLEAVAGE OF INITIATOR METHIONINE,
RP   ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RA   Bienvenut W.V., Peters C.;
RL   Submitted (JUN-2005) to UniProtKB.
RN   [5]
RP   INTERACTION WITH SRV2.
RX   PubMed=8552082; DOI=10.1128/mcb.16.2.548;
RA   Freeman N.L., Lila T., Mintzer K.A., Chen Z., Pahk A.J., Ren R.,
RA   Drubin D.G., Field J.;
RT   "A conserved proline-rich region of the Saccharomyces cerevisiae cyclase-
RT   associated protein binds SH3 domains and modulates cytoskeletal
RT   localization.";
RL   Mol. Cell. Biol. 16:548-556(1996).
RN   [6]
RP   INTERACTION WITH RVS167.
RX   PubMed=10388809; DOI=10.1093/genetics/152.3.881;
RA   Colwill K., Field D., Moore L., Friesen J., Andrews B.;
RT   "In vivo analysis of the domains of yeast Rvs167p suggests Rvs167p function
RT   is mediated through multiple protein interactions.";
RL   Genetics 152:881-893(1999).
RN   [7]
RP   FUNCTION, INTERACTION WITH ACTIN AND ARP2/3 COMPLEX, AND MUTAGENESIS OF
RP   201-ASP--TRP-203 AND 437-ASP--TRP-439.
RX   PubMed=11331312; DOI=10.1083/jcb.153.3.627;
RA   Goode B.L., Rodal A.A., Barnes G., Drubin D.G.;
RT   "Activation of the Arp2/3 complex by the actin filament binding protein
RT   Abp1p.";
RL   J. Cell Biol. 153:627-634(2001).
RN   [8]
RP   INTERACTION WITH SLA1, AND SUBCELLULAR LOCATION.
RX   PubMed=11950888; DOI=10.1242/jcs.115.8.1703;
RA   Warren D.T., Andrews P.D., Gourlay C.W., Ayscough K.R.;
RT   "Sla1p couples the yeast endocytic machinery to proteins regulating actin
RT   dynamics.";
RL   J. Cell Sci. 115:1703-1715(2002).
RN   [9]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RX   PubMed=14562095; DOI=10.1038/nature02026;
RA   Huh W.-K., Falvo J.V., Gerke L.C., Carroll A.S., Howson R.W.,
RA   Weissman J.S., O'Shea E.K.;
RT   "Global analysis of protein localization in budding yeast.";
RL   Nature 425:686-691(2003).
RN   [10]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A., Dephoure N.,
RA   O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [11]
RP   INTERACTION WITH APP1; PRK1; SCP1 AND YIR003W.
RX   PubMed=14737190; DOI=10.1371/journal.pbio.0020014;
RA   Landgraf C., Panni S., Montecchi-Palazzi L., Castagnoli L.,
RA   Schneider-Mergener J., Volkmer-Engert R., Cesareni G.;
RT   "Protein interaction networks by proteome peptide scanning.";
RL   PLoS Biol. 2:94-103(2004).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-181; SER-365 AND SER-481, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   STRAIN=ADR376;
RX   PubMed=17330950; DOI=10.1021/pr060559j;
RA   Li X., Gerber S.A., Rudner A.D., Beausoleil S.A., Haas W., Villen J.,
RA   Elias J.E., Gygi S.P.;
RT   "Large-scale phosphorylation analysis of alpha-factor-arrested
RT   Saccharomyces cerevisiae.";
RL   J. Proteome Res. 6:1190-1197(2007).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-169; THR-181; SER-183 AND
RP   SER-389, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17287358; DOI=10.1073/pnas.0607084104;
RA   Chi A., Huttenhower C., Geer L.Y., Coon J.J., Syka J.E.P., Bai D.L.,
RA   Shabanowitz J., Burke D.J., Troyanskaya O.G., Hunt D.F.;
RT   "Analysis of phosphorylation sites on proteins from Saccharomyces
RT   cerevisiae by electron transfer dissociation (ETD) mass spectrometry.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:2193-2198(2007).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-169; THR-181; SER-183;
RP   SER-313; SER-365; SER-389; SER-458 AND SER-481, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18407956; DOI=10.1074/mcp.m700468-mcp200;
RA   Albuquerque C.P., Smolka M.B., Payne S.H., Bafna V., Eng J., Zhou H.;
RT   "A multidimensional chromatography technology for in-depth phosphoproteome
RT   analysis.";
RL   Mol. Cell. Proteomics 7:1389-1396(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-165; SER-167; SER-169;
RP   THR-181; SER-313 AND SER-365, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19779198; DOI=10.1126/science.1172867;
RA   Holt L.J., Tuch B.B., Villen J., Johnson A.D., Gygi S.P., Morgan D.O.;
RT   "Global analysis of Cdk1 substrate phosphorylation sites provides insights
RT   into evolution.";
RL   Science 325:1682-1686(2009).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [17]
RP   UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-464, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22106047; DOI=10.1002/pmic.201100166;
RA   Starita L.M., Lo R.S., Eng J.K., von Haller P.D., Fields S.;
RT   "Sites of ubiquitin attachment in Saccharomyces cerevisiae.";
RL   Proteomics 12:236-240(2012).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (1.3 ANGSTROMS) OF SH3 DOMAIN, MUTAGENESIS OF
RP   TRP-569, AND INTERACTION WITH ARK1 AND PRK1.
RX   PubMed=11668184; DOI=10.1074/jbc.m109848200;
RA   Fazi B., Cope M.J.T.V., Douangamath A., Ferracuti S., Schirwitz K.,
RA   Zucconi A., Drubin D.G., Wilmanns M., Cesareni G., Castagnoli L.;
RT   "Unusual binding properties of the SH3 domain of the yeast actin-binding
RT   protein Abp1: structural and functional analysis.";
RL   J. Biol. Chem. 277:5290-5298(2002).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF ADF DOMAIN, MUTAGENESIS OF LYS-21;
RP   ARG-24; LYS-80; LYS-94; ARG-96; ASP-122; ASP-125 AND LYS-134, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=15872087; DOI=10.1091/mbc.e05-01-0059;
RA   Quintero-Monzon O., Rodal A.A., Strokopytov B., Almo S.C., Goode B.L.;
RT   "Structural and functional dissection of the Abp1 ADFH actin-binding domain
RT   reveals versatile in vivo adapter functions.";
RL   Mol. Biol. Cell 16:3128-3139(2005).
CC   -!- FUNCTION: Regulates ARP2/3 complex-mediated actin assembly. Recruits
CC       ARP2/3 complex to sides of preexisting actin filaments, which may
CC       promote nucleation or stabilization of filament branches. Binds to
CC       actin filaments, but not actin monomers. Actin binding is required for
CC       ARP2/3 complex activation. May also have a role in linking the actin
CC       cytoskeleton to endocytosis. recruits components of the endocytotic
CC       machinery to cortical actin patches, known sites of endocytosis.
CC       {ECO:0000269|PubMed:11331312}.
CC   -!- SUBUNIT: Binds F-actin, but not G-actin. Interacts with the ARP2/3
CC       complex. Interacts with APP1, ARK1, PRK1, SCP1, SRV2 and YIR003W via
CC       its SH3 domain. Interacts with the SH3 domain of RVS167 and with SLA1.
CC       {ECO:0000269|PubMed:10388809, ECO:0000269|PubMed:11331312,
CC       ECO:0000269|PubMed:11668184, ECO:0000269|PubMed:11950888,
CC       ECO:0000269|PubMed:14737190, ECO:0000269|PubMed:8552082}.
CC   -!- INTERACTION:
CC       P15891; P40563: AIM21; NbExp=10; IntAct=EBI-2036, EBI-25376;
CC       P15891; P53933: APP1; NbExp=11; IntAct=EBI-2036, EBI-28798;
CC       P15891; P53974: ARK1; NbExp=12; IntAct=EBI-2036, EBI-9817;
CC       P15891; Q06604: BSP1; NbExp=2; IntAct=EBI-2036, EBI-37047;
CC       P15891; Q12134: HUA2; NbExp=4; IntAct=EBI-2036, EBI-37262;
CC       P15891; P50942: INP52; NbExp=2; IntAct=EBI-2036, EBI-28834;
CC       P15891; P43603: LSB3; NbExp=6; IntAct=EBI-2036, EBI-22980;
CC       P15891; P40494: PRK1; NbExp=11; IntAct=EBI-2036, EBI-9703;
CC       P15891; P39743: RVS167; NbExp=6; IntAct=EBI-2036, EBI-14500;
CC       P15891; Q08873: SCP1; NbExp=7; IntAct=EBI-2036, EBI-33137;
CC       P15891; P32790: SLA1; NbExp=4; IntAct=EBI-2036, EBI-17313;
CC       P15891; P17555: SRV2; NbExp=9; IntAct=EBI-2036, EBI-4024;
CC       P15891; P32793: YSC84; NbExp=4; IntAct=EBI-2036, EBI-24460;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, actin patch
CC       {ECO:0000269|PubMed:11950888, ECO:0000269|PubMed:14562095,
CC       ECO:0000269|PubMed:15872087}. Note=Cortical actin patches.
CC   -!- PTM: The actin depolymerizing factor homology (ADF) domain mediates
CC       actin filament binding.
CC   -!- MISCELLANEOUS: Present with 606 molecules/cell in log phase SD medium.
CC       {ECO:0000269|PubMed:14562106}.
CC   -!- SIMILARITY: Belongs to the ABP1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X51780; CAA36075.1; -; Genomic_DNA.
DR   EMBL; X59720; CAA42253.1; -; Genomic_DNA.
DR   EMBL; BK006937; DAA07557.1; -; Genomic_DNA.
DR   PIR; S19503; LLBY.
DR   RefSeq; NP_010012.1; NM_001178794.1.
DR   PDB; 1HQZ; X-ray; 2.10 A; 1/2/3/4/5/6/7/8/9=1-141.
DR   PDB; 1JO8; X-ray; 1.30 A; A=535-592.
DR   PDB; 2K3B; NMR; -; A=535-592.
DR   PDB; 2RPN; NMR; -; A=535-592.
DR   PDBsum; 1HQZ; -.
DR   PDBsum; 1JO8; -.
DR   PDBsum; 2K3B; -.
DR   PDBsum; 2RPN; -.
DR   AlphaFoldDB; P15891; -.
DR   BMRB; P15891; -.
DR   SMR; P15891; -.
DR   BioGRID; 31060; 166.
DR   DIP; DIP-534N; -.
DR   IntAct; P15891; 50.
DR   MINT; P15891; -.
DR   STRING; 4932.YCR088W; -.
DR   iPTMnet; P15891; -.
DR   MaxQB; P15891; -.
DR   PaxDb; P15891; -.
DR   PRIDE; P15891; -.
DR   EnsemblFungi; YCR088W_mRNA; YCR088W; YCR088W.
DR   GeneID; 850450; -.
DR   KEGG; sce:YCR088W; -.
DR   SGD; S000000684; ABP1.
DR   VEuPathDB; FungiDB:YCR088W; -.
DR   eggNOG; KOG3655; Eukaryota.
DR   GeneTree; ENSGT00940000168710; -.
DR   HOGENOM; CLU_459326_0_0_1; -.
DR   InParanoid; P15891; -.
DR   OMA; HYASQYD; -.
DR   BioCyc; YEAST:G3O-29382-MON; -.
DR   Reactome; R-SCE-6798695; Neutrophil degranulation.
DR   Reactome; R-SCE-9013405; RHOD GTPase cycle.
DR   EvolutionaryTrace; P15891; -.
DR   PRO; PR:P15891; -.
DR   Proteomes; UP000002311; Chromosome III.
DR   RNAct; P15891; protein.
DR   GO; GO:0030479; C:actin cortical patch; IDA:SGD.
DR   GO; GO:0005938; C:cell cortex; IDA:SGD.
DR   GO; GO:0030864; C:cortical actin cytoskeleton; IBA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; HDA:SGD.
DR   GO; GO:0043332; C:mating projection tip; HDA:SGD.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0030427; C:site of polarized growth; IBA:GO_Central.
DR   GO; GO:0051015; F:actin filament binding; IDA:SGD.
DR   GO; GO:0000147; P:actin cortical patch assembly; IMP:SGD.
DR   GO; GO:0051016; P:barbed-end actin filament capping; IMP:SGD.
DR   GO; GO:2000601; P:positive regulation of Arp2/3 complex-mediated actin nucleation; IDA:SGD.
DR   GO; GO:0044379; P:protein localization to actin cortical patch; IMP:SGD.
DR   GO; GO:0030833; P:regulation of actin filament polymerization; IBA:GO_Central.
DR   CDD; cd11961; SH3_Abp1_fungi_C2; 1.
DR   Gene3D; 3.40.20.10; -; 1.
DR   InterPro; IPR035718; Abp1_fungi_SH3_C2.
DR   InterPro; IPR002108; ADF-H.
DR   InterPro; IPR029006; ADF-H/Gelsolin-like_dom_sf.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   Pfam; PF00241; Cofilin_ADF; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   SMART; SM00102; ADF; 1.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   PROSITE; PS51263; ADF_H; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Actin-binding; Cytoplasm; Cytoskeleton;
KW   Direct protein sequencing; Isopeptide bond; Phosphoprotein;
KW   Reference proteome; Repeat; SH3 domain; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|Ref.4, ECO:0007744|PubMed:22814378"
FT   CHAIN           2..592
FT                   /note="Actin-binding protein"
FT                   /id="PRO_0000064429"
FT   DOMAIN          7..136
FT                   /note="ADF-H"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00599"
FT   REPEAT          200..209
FT                   /note="1"
FT   REPEAT          436..445
FT                   /note="2"
FT   DOMAIN          532..592
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   REPEAT          566..575
FT                   /note="3"
FT   REGION          144..541
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          200..575
FT                   /note="3 X 10 AA approximate repeats (acidic)"
FT   COMPBIAS        144..170
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        233..248
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        279..294
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        295..309
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        336..378
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        397..411
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        427..446
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000269|Ref.4, ECO:0007744|PubMed:22814378"
FT   MOD_RES         165
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:19779198"
FT   MOD_RES         167
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19779198"
FT   MOD_RES         169
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17287358,
FT                   ECO:0007744|PubMed:18407956, ECO:0007744|PubMed:19779198"
FT   MOD_RES         181
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:17287358,
FT                   ECO:0007744|PubMed:17330950, ECO:0007744|PubMed:18407956,
FT                   ECO:0007744|PubMed:19779198"
FT   MOD_RES         183
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17287358,
FT                   ECO:0007744|PubMed:18407956"
FT   MOD_RES         313
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18407956,
FT                   ECO:0007744|PubMed:19779198"
FT   MOD_RES         365
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17330950,
FT                   ECO:0007744|PubMed:18407956, ECO:0007744|PubMed:19779198"
FT   MOD_RES         389
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17287358,
FT                   ECO:0007744|PubMed:18407956"
FT   MOD_RES         458
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18407956"
FT   MOD_RES         481
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17330950,
FT                   ECO:0007744|PubMed:18407956"
FT   CROSSLNK        464
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0007744|PubMed:22106047"
FT   MUTAGEN         21
FT                   /note="K->A: In ABP1-1; moderately reduces actin binding
FT                   and partially reduces ARP2/3 complex activation; when
FT                   associated with A-24."
FT                   /evidence="ECO:0000269|PubMed:15872087"
FT   MUTAGEN         24
FT                   /note="R->A: In ABP1-1; moderately reduces actin binding
FT                   and partially reduces ARP2/3 complex activation; when
FT                   associated with A-21."
FT                   /evidence="ECO:0000269|PubMed:15872087"
FT   MUTAGEN         80
FT                   /note="K->A: In ABP1-2; strongly reduces actin binding and
FT                   abolishes ARP2/3 complex activation."
FT                   /evidence="ECO:0000269|PubMed:15872087"
FT   MUTAGEN         94
FT                   /note="K->A: In ABP1-3; reduces actin binding and abolishes
FT                   ARP2/3 complex activation; when associated with A-96."
FT                   /evidence="ECO:0000269|PubMed:15872087"
FT   MUTAGEN         96
FT                   /note="R->A: In ABP1-3; reduces actin binding and abolishes
FT                   ARP2/3 complex activation; when associated with A-94."
FT                   /evidence="ECO:0000269|PubMed:15872087"
FT   MUTAGEN         122
FT                   /note="D->A: In ABP1-4; no effect; when associated with A-
FT                   125."
FT                   /evidence="ECO:0000269|PubMed:15872087"
FT   MUTAGEN         125
FT                   /note="D->A: In ABP1-4; no effect; when associated with A-
FT                   122."
FT                   /evidence="ECO:0000269|PubMed:15872087"
FT   MUTAGEN         134
FT                   /note="K->A: In ABP1-5; moderately reduces actin binding
FT                   and abolishes ARP2/3 complex activation."
FT                   /evidence="ECO:0000269|PubMed:15872087"
FT   MUTAGEN         201..203
FT                   /note="DDW->AAA: Abolishes ARP2/3 complex activation, but
FT                   not actin binding."
FT                   /evidence="ECO:0000269|PubMed:11331312"
FT   MUTAGEN         437..439
FT                   /note="DDW->AAA: Abolishes ARP2/3 complex activation, but
FT                   not actin binding."
FT                   /evidence="ECO:0000269|PubMed:11331312"
FT   MUTAGEN         569
FT                   /note="W->A: Abolishes protein binding."
FT                   /evidence="ECO:0000269|PubMed:11668184"
FT   CONFLICT        58
FT                   /note="L -> S (in Ref. 1; CAA36075)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        312
FT                   /note="K -> I (in Ref. 1; CAA36075)"
FT                   /evidence="ECO:0000305"
FT   HELIX           12..24
FT                   /evidence="ECO:0007829|PDB:1HQZ"
FT   STRAND          32..37
FT                   /evidence="ECO:0007829|PDB:1HQZ"
FT   STRAND          43..50
FT                   /evidence="ECO:0007829|PDB:1HQZ"
FT   HELIX           52..56
FT                   /evidence="ECO:0007829|PDB:1HQZ"
FT   STRAND          65..71
FT                   /evidence="ECO:0007829|PDB:1HQZ"
FT   STRAND          80..86
FT                   /evidence="ECO:0007829|PDB:1HQZ"
FT   HELIX           93..109
FT                   /evidence="ECO:0007829|PDB:1HQZ"
FT   STRAND          115..122
FT                   /evidence="ECO:0007829|PDB:1HQZ"
FT   HELIX           123..126
FT                   /evidence="ECO:0007829|PDB:1HQZ"
FT   HELIX           128..136
FT                   /evidence="ECO:0007829|PDB:1HQZ"
FT   STRAND          537..541
FT                   /evidence="ECO:0007829|PDB:1JO8"
FT   STRAND          546..550
FT                   /evidence="ECO:0007829|PDB:2RPN"
FT   STRAND          558..563
FT                   /evidence="ECO:0007829|PDB:1JO8"
FT   STRAND          566..574
FT                   /evidence="ECO:0007829|PDB:1JO8"
FT   TURN            575..577
FT                   /evidence="ECO:0007829|PDB:1JO8"
FT   STRAND          580..584
FT                   /evidence="ECO:0007829|PDB:1JO8"
FT   HELIX           585..587
FT                   /evidence="ECO:0007829|PDB:1JO8"
FT   STRAND          588..590
FT                   /evidence="ECO:0007829|PDB:1JO8"
SQ   SEQUENCE   592 AA;  65576 MW;  39523510704D94AA CRC64;
     MALEPIDYTT HSREIDAEYL KIVRGSDPDT TWLIISPNAK KEYEPESTGS SFHDFLQLFD
     ETKVQYGLAR VSPPGSDVEK IIIIGWCPDS APLKTRASFA ANFAAVANNL FKGYHVQVTA
     RDEDDLDENE LLMKISNAAG ARYSIQTSSK QQGKASTPPV KKSFTPSKSP APVSKKEPVK
     TPSPAPAAKI SSRVNDNNDD DDWNEPELKE RDFDQAPLKP NQSSYKPIGK IDLQKVIAEE
     KAKEDPRLVQ KPTAAGSKID PSSDIANLKN ESKLKRDSEF NSFLGTTKPP SMTESSLKND
     DDKVIKGFRN EKSPAQLWAE RKAKQNSGNA ETKAEAPKPE VPEDEPEGEP DVKDLKSKFE
     GLAASEKEEE EMENKFAPPP KKSEPTIISP KPFSKPQEPV KAEEAEQPKT DYKKIGNPLP
     GMHIEADNEE EPEENDDDWD DDEDEAAQPP LPSRNVASGA PVQKEEPEQE EIAPSLPSRN
     SIPAPKQEEA PEQAPEEEIE EEAEEAAPQL PSRSSAAPPP PPRRATPEKK PKENPWATAE
     YDYDAAEDNE LTFVENDKII NIEFVDDDWW LGELEKDGSK GLFPSNYVSL GN
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024